PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Virology, School of Medicine, Technische Universität München / Helmholtz Zentrum München, Trogerstr. 30, 81675 Munich, Germany.\', \'Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-Universität München, Butenandtstraße 5, 81377 Munich, Germany.\', \'Institute of Lung Biology and Disease (ILBD) and Comprehensive Pneumology Center (CPC) with the CPC-M bioArchive, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany.\', \'Department of Medicine V, University Hospital, LMU Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.\', \'Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Pulmonary Hospital; Marchioninistraße 15, 81377 Munich and Robert-Koch-Allee 2, 82131 Gauting, Germany.\', \'German Center for Infection Research (DZIF), Munich partner site, Germany.\', \'Infectious Diseases Therapeutic Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT), 34114 Daejeon, Republic of Korea.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/nar/gkab1248
?:doi
?:hasPublicationType
?:journal
  • Nucleic acids research
is ?:pmid of
?:pmid
?:pmid
  • 34928377
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.025
?:rankingScore_hIndex
  • 436
is ?:relation_isRelatedTo_publication of
?:title
  • Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all